Assyro AI

Orange Book product · Brand (NDA)

DESMODA

DESMOPRESSIN ACETATE

Brand (NDA)NDA 219873RX ETON

At a glance

Feb 25, 2026

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 25, 2026

    4 mo ago

  2. Today

  3. Patent 12214010 expires

    Listed drug product patent expiration.

    Apr 03, 2044

    in 18 yr 1 mo

  4. Patent 12343372 expires

    Listed drug product patent expiration.

    Apr 03, 2044

    in 18 yr 1 mo

Pharmaceutical detail

Active ingredient

DESMOPRESSIN ACETATE

Strength

0.05MG/ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 219873

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12214010Apr 03, 2044in 18 yr 1 mo
Product
12343372Apr 03, 2044in 18 yr 1 mo
ProductU-4432
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.